STING1 and neoplasm: The results obtained after i.t. injections confirmed those obtained after DMXAA i.p. Indeed, both i.t. STING agonists failed to induce tumor regression in Spont-PyMT mice, in sharp contrast with what was observed in the transplanted model (Fig. 1d).